This protocol is judged by an institutional evaluation board, an impartial group that evaluations any medical trials involving human beings. If a analyze entails a Timetable I drug, after the board approves the protocol as ethical, the researchers really have to make an application for an investigational new drug (IND) variety within the FDA.Access